Gardenia Blue

Arshine Group Co., Ltd. (Arshine Group for short) was founded in Shenzhen in 2007. Over the decades, Arshine has maintained sound development and rapid global expansion with an average annual growth rate of over 30%. Based on China and looking at the world, the Group has become a first-class and industry-leading professional health industry chain service group in China, with an annual turnover of over $150million.

Arshine Group supplies more than 2,000 kinds of products, covering the whole field of health industry, including human APIs, veterinary APIs, food additives, natural nutrition ingredients, feed additives, cosmetic additives, intermediates, pharmaceutical equipment, medical and pharmaceutical packaging materials, medical devices, etc. With global sourcing advantages, the group is fully capable of meeting the one-stop sourcing needs of global customers. Today, Arshine's marketing network has spread over more than 100 countries and regions on five continents, providing professional service for global customers.

Arshine Group has been highly recognized by all sectors of society since its establishment! Arshine is an AA Grade customer of Sinosure in Hunan Province and an AEO-accredited enterprise of China Customs. It has been certified by ISO9001 and EU FAMI-QS, and has obtained Class III Medical Device Trading Permit. As a member of the Board of Directors of the China Chamber of Commerce for Import & Export of Medicines & Health Products, Arshine has been awarded the title of "Quality Supplier and Partner in the International Market" by the Chamber in recent years. As the best human resource management company in Hunan Province, the Group has been awarded as Employer of the Year for several successive years.

In the future, Arshine Group will expand its business in the health industry, increase investment in R&D and production, and gradually become a trading, service and investment integrated group enterprise with trading business as its core. Arshinees will stay true to the mission of serving the global health industry and helping create a win-win situation.